Among HBV/HCV co-infection group, the active carriers (n = 7) have numerically higher post treatment ALT (29.0 U/L vs. 21 U/L vs. 18 U/L, p = 0.08) and less LSM reduction (−0.6 kPa vs. −0.8 kPa vs. −1.7 kPa, p = 0.234) compared with mono-HCV and inactive HBV carriers (n = 42) (Figure 1). This evidence concerns the gene GPT and coinfection.